Food and Drug Administration (FDA) for quality control problems in the past. Johnson & Johnson announced Wednesday, March 31, that a batch of its COVID-19 vaccine could not be used because it did not meet quality standards. Specifically, a vaccine ingredient made by Emergent BioSolutions at its Baltimore factory failed to meet quality standards. Johnson & Johnson said the factory, known as Bayview, had not yet been approved by the FDA to make part of the vaccine. It was unclear how many doses had been discarded and how the problem would affect future deliveries of Johnson & Johnson’s vaccine. But it was clear from the start that Emergent is a disaster waiting to happen for Johnson & Johnson. (Related: Johnson & Johnson threw out 15 MILLION DOSES of its coronavirus vaccine after sloppy worker mixed in the WRONG ingredient.)